Fecal Calprotectin Test Market is poised to value at a CAGR of over 13.1% during the forecast period 2021 to 2028. The Fecal Calprotectin test, which is a non-invasive laboratory test, is available and can serve as a useful tool in monitoring people with inflammatory bowel disease (Crohn's disease, ulcerative colitis, indeterminate colitis), thus distinguishing it from irritable bowel syndrome. 

For more info: https://www.futurewiseresearch.com/healthcare-market-research/Fecal-Calprotectin-Test/11728